Skip to main content
ARAY
NASDAQ Industrial Applications And Services

Accuray Reports Steep Q2 Losses, Cuts FY26 EBITDA Guidance Amid Major Restructuring

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.75
Mkt Cap
$85.754M
52W Low
$0.722
52W High
$2.95
52W Position info
3.8% above low
Off High info
75% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ARAY is trading near its 52-week low of $0.722 (3.8% above the low).

Summary

Accuray reported a significant Q2 net loss and negative Adjusted EBITDA, alongside a reduction in its full-year Adjusted EBITDA guidance, as it implements a major restructuring plan including a 15% workforce reduction.


Key Events · Earnings and Guidance · ARAY

  • Significant Q2 Financial Underperformance

    Accuray reported a net loss of $13.8 million ($0.11 per share) for Q2 FY26, a sharp decline from a net income of $2.5 million in the prior year. Adjusted EBITDA also turned negative at -$1.9 million, down from +$9.6 million year-over-year.

  • Revenue Decline and Margin Compression

    Total net revenue decreased by 12% to $102.2 million, driven by a 26% drop in product revenue. Gross profit margin fell significantly to 23.5% from 36.1% in the prior fiscal year's second quarter.

  • Reduced FY26 Adjusted EBITDA Guidance

    The company updated its fiscal year 2026 guidance, lowering expected Adjusted EBITDA to a range of $22 million to $25 million, down from the previous guidance of $31 million to $35 million.

  • Major Transformational Plan Underway

    Accuray initiated a comprehensive strategic and operational transformation plan in Q2, which includes organizational realignment, rightsizing of the cost structure, and workforce optimization affecting approximately 15% of its global employees. The plan is expected to generate $25 million in annualized operating profit improvement, with $12 million realized in FY26.


Analysis · ARAY · Industrial Applications And Services

Accuray Incorporated reported significantly weaker financial results for its second fiscal quarter, swinging to a substantial net loss and negative Adjusted EBITDA, while also reducing its full-year Adjusted EBITDA guidance. The company's revenue declined across both product and total net revenue, with gross profit margins also falling sharply. These poor results coincide with the implementation of a comprehensive transformational plan, which includes a 15% global workforce reduction and significant restructuring charges. This strategic overhaul, which follows the recent resignation of its Chief Commercial Officer, indicates the company is facing considerable operational challenges and is undertaking aggressive measures to improve profitability and competitiveness. Investors should monitor the execution of this transformation plan and its impact on future financial performance, especially given the stock's current position near 52-week lows.

At the time of this filing, ARAY was trading at $0.75 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $85.8M. The 52-week trading range was $0.72 to $2.95. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARAY - Latest Insights

ARAY
Jun 04, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3655
Real-time Price: $0.253 info
Change: -$0.1125 (-31%) info
Market Cap: $28.956M info
ARAY
May 22, 2026, 3:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.3077
Real-time Price: $0.253 info
Change: -$0.0547 (-18%) info
Market Cap: $28.956M info
ARAY
May 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.4105
Real-time Price: $0.253 info
Change: -$0.1575 (-38%) info
Market Cap: $28.956M info
ARAY
May 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4724
Real-time Price: $0.253 info
Change: -$0.2194 (-46%) info
Market Cap: $28.956M info
ARAY
Apr 28, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4455
Real-time Price: $0.253 info
Change: -$0.1925 (-43%) info
Market Cap: $28.956M info